By down-regulating c-MYC expression and augmenting acetylation of histone H4, compound 112 was found to suppress the growth of NMC and AML cell lines, but regrettably no synergistic effect was observed compared to the parent compound. The gene discussed is MYC; the disease is acute myeloid leukemia.